Experimental design
| Group | Route and Administration Method | Drug and Dose Administered |
|---|---|---|
| 1 | Intravenous (infusion) (0.5 ha) | SQV (48 mg) |
| 2 | Intravenous (bolus) | SQV (24 mg) |
| 3 | Intravenous (bolus) | SQV (12 mg) |
| 4 | Oral | SQV (48 mg) |
| 5 | Oral | SQV (24 mg) |
| 6 | Oral | SQV (12 mg) |
| 7 | Intraperitoneal | SQV (24 mg) |
| 8 | Intraperitoneal | SQV (12 mg) |
| 9 | Intravenous (infusion) (0.5 ha) | SQV (24 mg) and RTV (6 mg) |
| 10 | Oral | SQV (24 mg) and RTV (6 mg) |
↵a Infusion time.